Drug Search Results
More Filters [+]

IODINE-131

Alternative Names: iodine-131, iodine131, iodine 131
Latest Update: 2024-11-14
Latest Update Note: News Article

Product Description

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Corixa
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for IODINE-131

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Mantle-Cell Lymphoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT01484093

P2

Completed

Mantle-Cell Lymphoma

2023-08-11

Recent News Events